Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Helius Medical Technologies stock | $13.25

Learn how to easily invest in Helius Medical Technologies stock.

Helius Medical Technologies Inc is a medical devices business based in the US. Helius Medical Technologies shares (HSDT) are listed on the NASDAQ and all prices are listed in US Dollars. Helius Medical Technologies employs 19 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Helius Medical Technologies

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSDT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Helius Medical Technologies stock price (NASDAQ: HSDT)

Use our graph to track the performance of HSDT stocks over time.

Helius Medical Technologies shares at a glance

Information last updated 2021-10-16.
Latest market close$13.25
52-week range$11.00 - $18.45
50-day moving average $14.36
200-day moving average $15.36
Wall St. target price$2.12
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-8.68

Buy Helius Medical Technologies shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Helius Medical Technologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Helius Medical Technologies price performance over time

Historical closes compared with the close of $13.25 from 2021-10-21

1 week (2021-10-15) -8.18%
1 month (2021-09-23) -9.18%
3 months (2021-07-23) -15.87%
6 months (2021-04-23) -23.32%
1 year (2020-10-22) 2,967.13%
2 years (2019-10-22) 749.36%
3 years (2018-10-22) 30.41%
5 years (2016-10-21) 911.45%

Helius Medical Technologies financials

Revenue TTM $477,000
Gross profit TTM $273,000
Return on assets TTM -105.08%
Return on equity TTM -208.02%
Profit margin 0%
Book value $3.61
Market capitalisation $34.6 million

TTM: trailing 12 months

Shorting Helius Medical Technologies shares

There are currently 70,124 Helius Medical Technologies shares held short by investors – that's known as Helius Medical Technologies's "short interest". This figure is 11.3% down from 79,067 last month.

There are a few different ways that this level of interest in shorting Helius Medical Technologies shares can be evaluated.

Helius Medical Technologies's "short interest ratio" (SIR)

Helius Medical Technologies's "short interest ratio" (SIR) is the quantity of Helius Medical Technologies shares currently shorted divided by the average quantity of Helius Medical Technologies shares traded daily (recently around 11078.04107425). Helius Medical Technologies's SIR currently stands at 6.33. In other words for every 100,000 Helius Medical Technologies shares traded daily on the market, roughly 6330 shares are currently held short.

However Helius Medical Technologies's short interest can also be evaluated against the total number of Helius Medical Technologies shares, or, against the total number of tradable Helius Medical Technologies shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Helius Medical Technologies's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Helius Medical Technologies shares in existence, roughly 30 shares are currently held short) or 0.0383% of the tradable shares (for every 100,000 tradable Helius Medical Technologies shares, roughly 38 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Helius Medical Technologies.

Find out more about how you can short Helius Medical Technologies stock.

Helius Medical Technologies share dividends

We're not expecting Helius Medical Technologies to pay a dividend over the next 12 months.

Have Helius Medical Technologies's shares ever split?

Helius Medical Technologies's shares were split on a 1:35 basis on 3 January 2021. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Helius Medical Technologies shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Helius Medical Technologies shares which in turn could have impacted Helius Medical Technologies's share price.

Helius Medical Technologies share price volatility

Over the last 12 months, Helius Medical Technologies's shares have ranged in value from as little as $11 up to $18.45. A popular way to gauge a stock's volatility is its "beta".

HSDT.US volatility(beta: 0.84)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Helius Medical Technologies's is 0.8381. This would suggest that Helius Medical Technologies's shares are less volatile than average (for this exchange).

Helius Medical Technologies overview

Helius Medical Technologies, Inc. , a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania. .

Frequently asked questions

What percentage of Helius Medical Technologies is owned by insiders or institutions?
Currently 14.877% of Helius Medical Technologies shares are held by insiders and 26.173% by institutions.
How many people work for Helius Medical Technologies?
Latest data suggests 19 work at Helius Medical Technologies.
When does the fiscal year end for Helius Medical Technologies?
Helius Medical Technologies's fiscal year ends in December.
Where is Helius Medical Technologies based?
Helius Medical Technologies's address is: 642 Newtown Yardley Road, Newtown, PA, United States, 18940
What is Helius Medical Technologies's ISIN number?
Helius Medical Technologies's international securities identification number is: US42328V6039
What is Helius Medical Technologies's CUSIP number?
Helius Medical Technologies's Committee on Uniform Securities Identification Procedures number is: 42328V504

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site